Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 19.15% on an annualized basis producing an average annual return of 27.55%. Currently, Regeneron Pharmaceuticals has a market capitalization of $131.42 billion. Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $132,765.03 today based on a price of $1192.23 for REGN at the time of writing. Regeneron Pharmaceuticals’s Performance Over Last 20 YearsFinally — what’s the point of all this? The key insight to take from this article is to note how much of a…